Developing an iPSC-derived Human Microglia Platform to Engineer & Enable a Genetically Enriched Neuroimmune Pipeline

Time: 9:00 am
day: Conference Day One


  • Deciphering the information that can be obtained from neuroimmune iPSC-derived models
  • Applying CRISPR screens to evaluate the functional consequences of genetic perturbations in iPSC-derived human microglia
  • Developing a scalable high-throughput iPSC-derived model system for target validation